One trial examining semaglutide in individuals with AUD demonstrated lower alcohol intake, but reported inconsistent effects on heavy drinking days
Compounded semaglutide is a customized version of the medication, prepared by our partner, Belmar Pharma Solutions
Highlights from study findings include: 751 individuals participated in the study The mean percent change in weight at week 72 was -20.2% for those taking tirzepatide and -13.7% for those taking semaglutide The most common side effects were gastrointestinal A 2025 real-world study of over 2,300 patients treated at an academic obesity clinic also showed meaningful weight loss, especially among those who stayed on therapy for at least a year
EFSA J 732:115 Costerton JW, Cheng KJ, Geesey GG, Ladd TI, Nickel JC, Dasgupta M, Marrie TJ (1987) Bacterial biofilms in nature and disease
You dont want to begin taking a weight loss pill with unrealistic expectations, as that could lead to disappointment and frustration